Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer’s disease

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429

Mild Cognitive Impairment: Clinical Characterization and Outcome

Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980

Mild cognitive impairment as a diagnostic entity

Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864

The Bcl-2 Protein Family: Arbiters of Cell Survival

Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,334

Current concepts in mild cognitive impairment

Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514

Chemokines — Chemotactic Cytokines That Mediate Inflammation

Luster, A. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380706 · Cited by 3,633

Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease

Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,871

Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice

Lu, B., RUTLEDGE, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R. J., Gerard, C. J., & Rollins, B. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.601 · Cited by 1,017

Early alterations in blood and brain RANTES and MCP-1 expression and the effect of exercise frequency in the 3xTg-AD mouse model of Alzheimer’s disease

Haskins, M., Jones, T. E., Lu, Q., & Bareiss, S. K. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.11.002 · Cited by 29

Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness

Kelsven, S., de la Fuente‐Sandoval, C., Achim, C. L., Reyes-Madrigal, F., Mirzakhanian, H., Domingues, I., & Cadenhead, K. S. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.01.003 · Cited by 29

Cerebrospinal Fluid and Blood CX3CL1 as a Potential Biomarker in Early Diagnosis and Prognosis of Dementia

Kulczyńska‐Przybik, A., Słowik, A., Mroczko, P., Borawski, B., Groblewska, M., Borawska, R., & Mroczko, B. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666201109095657 · Cited by 29

Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer

Janelsins, M. C., Lei, L., Netherby-Winslow, C., Kleckner, A. S., Kerns, S. L., Gilmore, N. J., Belcher, E. K., Thompson, B. D., Werner, Z. A., Hopkins, J. O., et al. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577769 · Cited by 29

Prep1/Pbx2 complexes regulate CCL2 expression through the −2578 guanine polymorphism

Wright, E. K., Page, S. H., Barber, S. A., & Clements, J. E. (2008) · Genes and Immunity · doi:10.1038/gene.2008.33 · Cited by 29

Monocytes deliver bioactive nerve growth factor through a brain capillary endothelial cell-monolayer in vitro and counteract degeneration of cholinergic neurons

Böttger, D., Ullrich, C., & Humpel, C. (2009) · Brain Research · doi:10.1016/j.brainres.2009.11.062 · Cited by 29

Inflammatory Mediators in the Frontal Lobe of Patients with Mixed and Vascular Dementia

Mulugeta, E., Molina‐Holgado, F., Elliott, M. S. J., Hortobágyi, T., Perry, R., Kalaria, R. N., Ballard, C. G., & Francis, P. T. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000118633 · Cited by 29

A Link Between Nerve Growth Factor Metabolic Deregulation and Amyloid-β-Driven Inflammation in Down Syndrome

Iulita, M. F., Caraci, F., & Cuello, A. C. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666160321104916 · Cited by 28

Selective Elevation of Circulating CCL2/MCP1 Levels in Patients with Longstanding Post-vaccinal Macrophagic Myofasciitis and ASIA

Cadusseau, J., Ragunathan, N., Surénaud, M., Hüe, S., Authier, F., & Gherardi, R. K. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113206660287 · Cited by 28

Neuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets

Herman, F. J., Simkovic, S. J., & Pasinetti, G. M. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14569 · Cited by 29

Chemokine MCP1 is associated with cognitive flexibility in schizophrenia: A preliminary analysis

Klaus, F., Mitchell, K. R., Liou, S. C., Eyler, L. T., & Nguyen, T. T. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.04.007 · Cited by 30

Practical detection of a definitive biomarker panel for Alzheimer's disease; comparisons between matched plasma and cerebrospinal fluid.

Richens, J. L., Vere, K., Light, R., Soria, D., Garibaldi, J. M., Smith, A. D., Warden, D. R., Wilcock, G. K., Bajaj, N. P. S., Morgan, K., et al. (2014) · PubMed Central · Cited by 25

Longitudinal chemokine profile expression in a blood-brain barrier model from Alzheimer transgenic versus wild-type mice

Vérité, J., Janet, T., Chassaing, D., Fauconneau, B., Rabeony, H., & Page, G. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1220-7 · Cited by 25

Identifying biomarkers of dementia prevalent among amnestic mild cognitively impaired ethnic female patients

Grewal, R., Haghighi, M., Huang, S., Smith, A., Cao, C., Lin, X., Lee, D. C., Teten, N., Hill, A. M., & Selenica, M. B. (2016) · Alzheimer s Research & Therapy · doi:10.1186/s13195-016-0211-0 · Cited by 25

Elevated Monocyte Chemoattractant Protein-1 as the Independent Risk Factor of Delirium after Cardiac Surgery. A Prospective Cohort Study

Kaźmierski, J., Miler, P., Pawlak, A., Jerczyńska, H., Woźniak, J., Frankowska, E., Brzezińska, A., Woźniak, K., Krejca, M., & Wilczyński, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081587 · Cited by 24

Plasma MCP-1 and changes on cognitive function in community-dwelling older adults

Sánchez‐Sánchez, J. L., Giudici, K. V., Guyonnet, S., Delrieu, J., Li, Y., Bateman, R. J., Parini, A., Vellas, B. J., Barreto, P. D. S., for the MAPT/DSA Group, et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00940-2 · Cited by 25

Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer’s Disease: From Animal Models to the Human Pathology

Lattanzi, R., Maftei, D., Petrella, C., Pieri, M., Sancesario, G. M., Schirinzi, T., Bernardini, S., Barbato, C., Ralli, M., Greco, A., et al. (2019) · Cells · doi:10.3390/cells8111430 · Cited by 25

Characterisation of amyloid-induced inflammatory responses in the rat retina

Howlett, D. R., Bate, S. T., Collier, S., Lawman, A. J., Chapman, T. D., Ashmeade, T. E., Marshall, I. C. B., Anderson, P. J., Philpott, K. L., Richardson, J. C., et al. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2819-4 · Cited by 22

Decreased levels of cytokines implicate altered immune response in plasma of moderate-stage Alzheimer’s disease patients

Koca, S., Kiris, İ., Şahin, Ş., Çınar, N., Karşıdağ, S., Hanağası, H. A., Yıldız, G. B., & Baykal, A. T. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136799 · Cited by 23

Monocyte chemoattractant protein-1 promoter polymorphism and plasma levels in alzheimer’s disease

Porcellini, E., Ianni, M., Carbone, I., Franceschi, M., & Licastro, F. (2013) · Immunity & Ageing · doi:10.1186/1742-4933-10-6 · Cited by 22

Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease

Minami, S., Sidahmed, E., Aïd, S., Shimoji, M., Niikura, T., Mocchetti, I., Rebeck, G. W., Prendergast, J., Dealwis, C. G., Wetzel, R. B., et al. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-57 · Cited by 26

The Chemokine (C-C Motif) Ligand 2 in Neuroinflammation and Neurodegeneration

Madrigal, J. L. M., & Caso, J. R. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-07320-0_15 · Cited by 21

Functions of glutaminyl cyclase and its isoform in diseases

Liu, Y., Shi, Y., & Wang, P. (2023) · Visualized Cancer Medicine · doi:10.1051/vcm/2022008 · Cited by 20

Mouse strain and brain region‐specific expression of the glutaminyl cyclases QC and isoQC

Höfling, C., Indrischek, H., Höpcke, T., Waniek, A., Cynis, H., Koch, B. M., Schilling, S., Morawski, M., Demuth, H., Roßner, S., et al. (2014) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2014.05.008 · Cited by 20

Neuroinflammatory changes increase the impact of stressors on neuronal function

Piazza, A., & Lynch, M. A. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370303 · Cited by 20

Inflammatory Markers and their Relationship with Cognitive Function in Alzheimer’s Disease and Mild Cognitive Impairment. Systematic Review and Meta-Analysis

Serna-Orozco, M. F., Mosquera, M., & García‐Perdomo, H. A. (2025) · NeuroMolecular Medicine · doi:10.1007/s12017-025-08866-w · Cited by 23

Body mass index, inflammatory biomarkers and neurocognitive impairment in HIV-infected persons

Okafor, C. N., Kelso, N. E., Bryant, V. E., Burrell, L. E., Míguez, M. J., Gongvatana, A., Tashima, K. T., de la Monte, S. M., Cook, R. L., & Cohen, R. A. (2016) · Psychology Health & Medicine · doi:10.1080/13548506.2016.1199887 · Cited by 19

Dietary Galacto‐Oligosaccharides and Resistant Starch Protect Against Altered CB1 and 5‐HT1A and 2A Receptor Densities in Rat Brain: Implications for Preventing Cognitive and Appetite Dysfunction During a High‐Fat Diet

Yu, Y., Patch, C. S., Weston–Green, K., Zhou, Y., Zheng, K., & Huang, X. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800422 · Cited by 19

Inflammatory Biomarkers and Cognitive Decline: The Ginkgo Evaluation of Memory Study

Sharma, M., Fitzpatrick, A. L., Arnold, A. M., Chi, G., López, O. L., Jenny, N. S., & DeKosky, S. T. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14140 · Cited by 19

Epigenetic regulation of CC-chemokine ligand 2 in nonresolving inflammation

Kiguchi, N., Saika, F., Kobayashi, Y., & Kishioka, S. (2014) · BioMolecular Concepts · doi:10.1515/bmc-2014-0022 · Cited by 18

MCP-1 and CCR2 gene polymorphisms in Parkinson’s disease in a Han Chinese cohort

Gao, L., Tang, H., Nie, K., Wang, L., Zhao, J., Gan, R., Huang, J., Feng, S., Zhu, R., Duan, Z., et al. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1990-3 · Cited by 18

Chemokines in systemic lupus erythematosus involving the central nervous system

Kasama, T. (2007) · Frontiers in bioscience · doi:10.2741/2864 · Cited by 18

Chemokines in patients with Alzheimer's disease: A meta-analysis

Wang, H., Zong, Y., Zhu, L., Wang, W., & Han, Y. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1047810 · Cited by 19

Candidate gene analysis of IP-10 gene in patients with Alzheimer's disease

Venturelli, E., Galimberti, D., Fenoglio, C., Lovati, C., Finazzi, D., Guidi, I., Corrà, B., Scalabrini, D., Clerici, F., Mariani, C. B., et al. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.05.054 · Cited by 17

Plasma cytokines profile in patients with Alzheimer’s and Parkinson’s Disease: a comparative study in terms of inflammation

Shateri, S., Khatami, S. H., Toutounchi, A. H., Rajaei, S., Mahdavi, M., Baram, S. M., Shahidi, G. A., Habibi, A. H., Aghamollaii, V., Ghlichnia, B., et al. (2023) · International Journal of Neuroscience · doi:10.1080/00207454.2023.2292951 · Cited by 16

Definition and Quantification of Six Immune- and Neuroregulatory Serum Proteins in Healthy and Demented Elderly

Schipke, C. G., Gunter, O. L., Weinert, C., Scotton, P., Sigle, J.-P., Kallarackal, J., Kabelitz, D., Finzen, A., & Feuerhelm, A. (2019) · Neurodegenerative Disease Management · doi:10.2217/nmt-2019-0003 · Cited by 17

Alzheimer's Disease: Fatty Acids We Eat may be Linked to a Specific Protection via Low-dose Aspirin.

Pomponi, M. F. L., Gambassi, G., Pomponi, M., & Masullo, C. (2010) · Europe PMC (PubMed Central) · Cited by 15

Blood levels of MCP‐1 modulate the genetic risks of Alzheimer's disease mediated by HLA‐DRB1 and APOE for Alzheimer's disease

Huang, J., Stein, T. D., Wang, Y., Ang, T. F. A., Tao, Q., Lunetta, K. L., Massaro, J., Akhter‐Khan, S. C., Mez, J., Au, R., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12851 · Cited by 14

Can Genetic Analysis of Putative Blood Alzheimer’s Disease Biomarkers Lead to Identification of Susceptibility Loci?

Barber, R. C., Phillips, N., Tilson, J. L., Huebinger, R. M., Shewale, S., Koenig, J. L., Mitchel, J. S., O’Bryant, S. E., Waring, S. C., Diaz-Arrastia, R. R., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142360 · Cited by 14

A Preliminary Study of Cu Exposure Effects upon Alzheimer’s Amyloid Pathology

Pilozzi, A. R., Yu, Z., Carreras, I., Cormier, K., Hartley, D. M., Rogers, J. T., Dedeoglu, A., & Huang, X. (2020) · Biomolecules · doi:10.3390/biom10030408 · Cited by 14

Neuroinflammation and Disease: Pathways and Opportunities

Hoffman, O., Varvel, N. H., Roopra, A., & Dingledine, R. J. (2025) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-062124-043519 · Cited by 14

Estimation of blood-based biomarkers of glial activation related to neuroinflammation

Yasuno, F., Watanabe, A., Kimura, Y., Yamauchi, Y., Ogata, A., Ikenuma, H., Abe, J., Minami, H., Nihashi, T., Yokoi, K., et al. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100549 · Cited by 12

MCP-1 levels in astrocyte-derived exosomes are changed in preclinical stage of Alzheimer's disease

Wang, T., Yao, Y., Han, C., Li, T., Du, W., Xue, J., Han, Y., & Cai, Y. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1119298 · Cited by 13

Active Fraction Combination from Liuwei Dihuang Decoction (LW-AFC) Alleviated the LPS-Induced Long-Term Potentiation Impairment and Glial Cells Activation in Hippocampus of Mice by Modulating Immune Responses

Ju, Z., Cheng, B., Huang, Y. Y., Zhang, X., Wang, C., Sun, N., Liu, G., Cheng, X., Zhang, Y., & Zhou, W. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/3040972 · Cited by 12

Cadmium induces CCL2 production in glioblastoma cells via activation of MAPK, PI3K, and PKC pathways

Kasemsuk, T., Phuagkhaopong, S., Yubolphan, R., Rungreangplangkool, N., & Vivithanaporn, P. (2020) · Journal of Immunotoxicology · doi:10.1080/1547691x.2020.1829211 · Cited by 12

HDAC Inhibitors recapitulate Human Disease-Associated Microglia Signatures in vitro

Haage, V. C., Tuddenham, J. F., Bautista, A. R., Garcia, F. G., White, C. C., Patel, R., Comandante-Lou, N., Marshe, V. S., Griffin, J. K., Zhou, Y., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.05.027 · Cited by 23

Alterations in Alzheimer’s Disease-Associated Gene Expression in Severe Obstructive Sleep Apnea Patients

Li, H., Tsai, M., Huang, C., Wang, R., Chuang, L., Chen, N., Liu, C., Hsu, C., Cheng, W., & Lee, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091361 · Cited by 11

Effects of Hydrogen Gas Inhalation on Community-Dwelling Adults of Various Ages: A Single-Arm, Open-Label, Prospective Clinical Trial

Rahman, M. H., Bajgai, J., Sharma, S., Jeong, E., Goh, S. H., Jang, Y.-G., Kim, C.-S., & Lee, K. (2023) · Antioxidants · doi:10.3390/antiox12061241 · Cited by 11

Association of plasma endothelial lipase levels on cognitive impairment

Yun, S., Park, J.-Y., Seo, S. W., & Song, J. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2174-8 · Cited by 10

In a circuit necessary for cognition and emotional affect, Alzheimer's-like pathology associates with neuroinflammation, cognitive and motivational deficits in the young adult TgF344-AD rat

Hernandez, C. M., McCuiston, M. A., Davis, K., Halls, Y., Zotto, J. P. C. D., Jackson, N. L., Dobrunz, L. E., King, P. H., & McMahon, L. L. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100798 · Cited by 11

Plasma Cytokines Profile in Subjects with Alzheimer’s Disease: Interleukin 1 Alpha as a Candidate for Target Therapy

Mahdavi, M., Karima, S., Rajaei, S., Aghamolaii, V., Ghahremani, H., Ataeia, R., Tehrani, H. S., Baram, S. M., Tafakhori, A., Lima, B. S., et al. (2021) · Galen Medical Journal · doi:10.31661/gmj.v10i0.1974 · Cited by 10

Differential chemokine expression under the control of peripheral blood mononuclear cells issued from Alzheimer’s patients in a human blood brain barrier model

Vérité, J., Page, G., Paccalin, M., Julian, A., & Janet, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201232 · Cited by 10

Neurovascular Dysfunction in Alzheimer Disease

Cipollini, V., Sette, G., Bossù, P., Ciaramella, A., Salani, F., Carolis, A. D., Troili, F., Orzi, F., & Giubilei, F. (2019) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000331 · Cited by 10

Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver Disease

Fiorillo, A., Gallego, J., Casanova‐Ferrer, F., Giménez‐Garzó, C., Urios, A., Ballester, M. P., Durbán, L., Ríos, M.-P., Megías, J., San‐Miguel, T., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210407 · Cited by 13

Influence of plasma cytokine levels on the conversion risk from MCI to dementia in the Alzheimer's disease neuroimaging initiative database

Abe, K., Chiba, Y., Hattori, S., Tamazawa, A., Yoshimi, A., Katsuse, O., & Suda, A. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116829 · Cited by 9

Serum Amyloidogenic Nanoplaques and Cytokines in Alzheimer’s Disease: Pilot Study in a Small Naturalistic Memory Clinic Cohort

Aksnes, M., Aass, H. C. D., Tiiman, A., Terenius, L. Y., Bogdanović, N., Vukojević, V. B., & Knapskog, A. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215504 · Cited by 9

The retinoid, 6-[3-adamantyl-4-hydroxyphenyl]-2-napthalene carboxylic acid, controls proliferative, morphological, and inflammatory responses involved in microglial activation without cytotoxic effects

Farso, M. C., Krantic, S. M., Rubio, M., Sarfati, M., & Quirion, R. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.053 · Cited by 9

The Development of Small Molecule Inhibitors of Glutaminyl Cyclase and Isoglutaminyl Cyclase for Alzheimer's Disease

Xu, A., He, F., Yu, C., Qu, Y., Zhang, Q., Lv, J., Zhang, X., Ran, Y., Wei, C., & Wu, J. (2019) · ChemistrySelect · doi:10.1002/slct.201902852 · Cited by 9

Spiegelmer NOX-E36 for Renal Diseases

Eulberg, D., Purschke, W. G., Anders, H., Selve, N., & Klußmann, S. (2008) · Royal Society of Chemistry eBooks · doi:10.1039/9781847558275-00200 · Cited by 9

Association of Inflammation and Possible Mild Cognitive Decline Measured by the Stroop Cognitive Function Test

Fabregue, F., & Butkowski, E. (2016) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000237 · Cited by 8

Effect of β-Alanine Supplementation on Monocyte Recruitment and Cognition During a 24-Hour Simulated Military Operation.

Wells, A., Varanoske, A. N., Coker, N., Kozlowski, G. J., Frosti, C. L., Boffey, D., Harat, I., Jahani, S., Gepner, Y., & Hoffman, J. (2020) · Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000003809 · Cited by 6

HDAC Inhibitors recapitulate Human Disease-Associated Microglia Signatures in vitroPreprint

Haage, V. C., Tuddenham, J. F., Bautista, A. R., White, C. C., Garcia, F. G., Patel, R., Comandante-Lou, N., Marshe, V. S., Soni, R. K., Sims, P. A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.11.617544 · Cited by 8

Alzheimer's disease and the immune system: A comprehensive overview with a focus on B cells, humoral immunity, and immunotherapy

Afrakoti, L. G. M. P., Moghadam, S. D., & Hadinezhad, P. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251329188 · Cited by 12

Muscle-brain crosstalk as a driver of brain health in aging

McNeish, B. L., Miljkovic, I., Liu-Ambrose, T. Y. L., Ambrosio, F., Esser, K. A., Fahnestock, M. L., & Rosano, C. (2025) · GeroScience · doi:10.1007/s11357-025-01833-0 · Cited by 10

Multiple cytokines are involved in the early events leading to the Alzheimer's disease pathology.

Wilberding, A., Morimoto, K., Satoh, H., Harano, K., Harano, T., Arita, S., Tooyama, I., & Konishi, Y. (2008) · PubMed · Cited by 7

Chemoattractants and receptors in Alzheimer s disease

Le, Y. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s81 · Cited by 7

Clinical Benefits of Exogenous Ketosis in Adults with Disease: A Systematic Review

Mohib, O., Bomans, S., Garcia, B. J., Leemans, L., Ligneel, C., Waele, E. D., Beckwée, D., & Janssens, P. (2025) · Nutrients · doi:10.3390/nu17193125 · Cited by 7

The CCL2 rs4586 SNP Is Associated with Slower Amyloid-β Deposition and Faster Tau Accumulation of Alzheimer’s Disease

Gao, F., Initiative, A. D. N., Zhang, P., Gao, J., Song, J., & Chi, S. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220716 · Cited by 7

Alcohol-Induced Activation of Chemokine System and Neuroinflammation Development

Викторовна, М. Е., Vyalova, N. M., Bokhan, N. A., & Ivanova, S. А. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924110038 · Cited by 7

Short-term exposure to dietary cholesterol is associated with downregulation of interleukin-15, reduced thigmotaxis and memory impairment in mice

Mayagoitia, K., Shin, S., Rubini, M., Siebold, L., Wilson, C. G., Bellinger, D. L., Figueroa, J. D., & Soriano, S. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112779 · Cited by 6

Long-Term Stability and Age-Dependence of Six Regulatory Serum Proteins

Menne, F., Schipke, C. G., Clark, C., & Popp, J. (2022) · Biomarkers in Medicine · doi:10.2217/bmm-2021-0518 · Cited by 6

Peripheral Inflammatory Biomarkers of Alzheimer’s Disease

Hao, J., Guo, Y., Guo, K., & Yang, Q. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215422 · Cited by 5

Compound 4f, a novel brain-penetrant reversible monoacylglycerol inhibitor, ameliorates neuroinflammation, neuronal cell loss, and cognitive impairment in mice with kainic acid-induced neurodegeneration

Arimura, N., Maeda, C., Aoyama, K., Yamaguchi, N., Sugiura, A., Takahashi, Y., Maeda, R., Ando, T., Kamata, M., Matsui, H., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0312090 · Cited by 4

Cognitive dysfunction in schizophrenia: association with peripheral blood inflammatory signatures

Luan, P., Wang, Q., Sun, Y., Jiang, C., Yin, J., & Wang, J. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07479-8 · Cited by 4

Interactive effects of blood–brain barrier breakdown and Alzheimer's disease biomarker status on cognitive decline in older adults without dementia

Edwards, L., Gonzalez, A. I., Thomas, K. R., Smirnov, D. S., Brenner, E. K., Nation, D. A., Chang, F., Blennow, K., Salmon, D. P., Galasko, D., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70910 · Cited by 4

Effects of mammary cancer and chemotherapy on neuroimmunological markers and memory function in a preclinical mouse model

Netherby-Winslow, C., Thompson, B. D., Lotta, L. T., Gallagher, M., Haute, P. V., Yang, R., Hott, D., Hasan, H., Bachmann, K. N., Bautista, J., et al. (2023) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2023.100699 · Cited by 4

Loss of APP in mice increases thigmotaxis and is associated with elevated brain expression of IL-13 and IP-10/CXCL10

Mayagoitia, K., Tolan, A. J., Shammi, S., Shin, S. D., Menchaca, J. A., Figueroa, J. D., Wilson, C. G., Bellinger, D. L., Ahmed, A. S. I., & Soriano, S. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113533 · Cited by 4

Correlation between MCP-1-2518A/G polymorphism and the risk of Alzheimer’s disease

Wang, Y., Huang, S., Wu, X., Wang, Y., & Jiang, D. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1936-7 · Cited by 4

Health for life. Your lifestyle, your genes, and cancer.

Weinberg, R. A., & Komaroff, A. L. (2008) · PubMed · Cited by 4

The impact of blood MCP-1 levels on Alzheimer’s disease with genetic variation of UNC5C and NAV3 lociPreprint

Huang, J., Wang, Y., Stein, T. D., Ang, T. F. A., Zhu, Y., Tao, Q., Lunetta, K. L., Mez, J. B., Au, R., Farrer, L. A., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3376348/v1 · Cited by 4

Chronic kidney disease and cardiac remodeling potentiate cognitive impairment progression: disentangling the sex-specific cross talk of kidney-heart-brain axis

Pillai, S. S., Morrell, C. H., dos Santos, C. R., Lakhani, H. V., Gonçalves, B. D. S., Pereira, D. G., Thakur, A., Thompson, E. A., Wei, W., Nayyar, A., et al. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00617.2025 · Cited by 4

Cerebrospinal fluid YKL‐40 level evolution is associated with autoimmune encephalitis remission

Dorcet, G., Bénaiteau, M., Pariente, J., Ory‐Magne, F., Cheuret, E., Rafiq, M., Brooks, W. H., Puissant‐Lubrano, B., Fortenfant, F., Renaudineau, Y., et al. (2023) · Clinical & Translational Immunology · doi:10.1002/cti2.1439 · Cited by 4

Interleukin 1 Receptor and Alzheimer’s Disease-Related Neuroinflammation

Wang, H., & Wang, X. (2017) · InTech eBooks · doi:10.5772/intechopen.69067 · Cited by 4

The impact of blood MCP-1 levels on Alzheimer’s disease with genetic variation at the NAV3 and UNC5C loci

Huang, J., Wang, Y., Stein, T. D., Ang, T. F. A., Zhu, Y., Tao, Q., Lunetta, K. L., Mez, J., Au, R., Farrer, L. A., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03542-w · Cited by 8

Microglia–astrocyte crosstalk as a key organizing principle of Alzheimer’s disease: from homeostatic cooperation to maladaptive signaling loops

Gong, M., Lan, J. X., & Miao, J. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1908574 · Cited by 3

Advances in the study of the role of chemokines in drug addiction and the potential effects of traditional Chinese medicines

Liu, Z.-X., Wang, X., Haghparast, A., He, W., & Zhang, J. (2023) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2023.100025 · Cited by 2

Co Expression of GMFβ, IL33, CCL2 and SDF1 Genes in the Acute Stage of Toxoplasmosis in Mice Model and Relation for Neuronal Impairment

Najafi, M., Amini, R., Maghsood, A. H., Fallah, M., & Foroughi-Parvar, F. (2021) · Iranian Journal of Parasitology · doi:10.18502/ijpa.v16i3.7096 · Cited by 2

Pro-Inflammatory Substances and Cognition in the Dallas Heart Study

Bernardo, K. A., Rossetti, H. C., Weiner, M., Cullum, C. M., de Lemos, J. A., & Lacritz, L. H. (2016) · Open Journal of Psychiatry · doi:10.4236/ojpsych.2016.61011 · Cited by 1

Chemokine Ligand 2 – Chemokines Receptor 2 As A Noval Drug Target

Gamit, K. S. (2022) · Open Access Journal of Toxicology · doi:10.19080/oajt.2022.05.555665 · Cited by 1

Plasma Cytokines Profile in Subjects with Alzheimer’s Disease: Interleukin 1 Alpha as a Candidate for Target Therapy

Karima, S., Mahdavi, M., Rajaei, S., Lima, B. S., Ataeia, R., Tehrani, H. S., Baram, S. M., Tafakhori, A., Shateri, S., Fatemi, H., et al. (2021) · Galen Medical Journal · doi:10.31661/gmj.v10i.1974 · Cited by 1

Causal relationships between monocyte chemoattractant protein-1 levels and neuropsychiatric disorders: Evidence from large-scale genetic data

He, Y., Hu, W., Li, Y., & Han, Z. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578767 · Cited by 1

Reprogramming Neuroinflammation: Mitochondrial Targets and Immune Checkpoint Inhibitors in Alzheimer’s Disease

Kumar, N., Mir, P. A., Bhutia, G. T., Chaudhary, P., Kaur, G., Alam, Q., Pawar, S. D., & Gupta, S. K. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05983-w · Cited by 1

Contribution of Neuroinflammation in the Pathogenesis of Alzheimer’s Disease

Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00006-9 · Cited by 1

Alzheimer’s Disease

Ikezu, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_30 · Cited by 1

Role of Chemokines and Chemokine Receptors in Diseases of Ageing

Mariani, E., Mariani, A. R., & Facchini, A. (2008) · Springer eBooks · doi:10.1007/978-0-387-76842-7_9 · Cited by 1

New Perspectives for the Treatment of Alzheimer’s Disease~!2008-10-07~!2008-10-30~!2008-11-26~!

Galimberti, D., & Scarpini, E. A. (2008) · The Open Geriatric Medicine Journal · doi:10.2174/1874827900801010033 · Cited by 1

Alzheimer’s disease: from pathogenesis to novel therapeutic approaches

Scarpini, E. A., & Galimberti, D. (2009) · Therapy · doi:10.2217/14750708.6.2.259 · Cited by 1

Peripheral Biomarkers of Excitotoxicity in Neurological Diseases

Tremolizzo, L., Sala, G., & Ferrarese, C. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9838-3_7

The Society for Neuroscience 2009 Meeting Report, Part 3

Landhuis, E. W.-Y. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1358

New Perspectives for the Treatment of Alzheimer's Disease

Galimberti, D., & Scarpini, E. A. (2008) · The Open Geriatric Medicine Journal

P2–138: Chemokine serum levels in mild cognitive impairment as Alzheimer's disease early biomarkers

Galimberti, D., Fenoglio, C., Lovati, C., Venturelli, E., Guidi, I., Corrà, B., Scalabrini, D., Clerici, F., Mariani, C. B., Bresolin, N., et al. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.976

Monocyte Chemoattractant Protein‐1 and its role in Alzheimer’s Disease: A Longitudinal Study

Virdi, J., Schlinger, B. A., & Silverman, D. H. S. (2025) · Alzheimer s & Dementia · doi:10.1002/alz70861_109030

P1‐108: Plasma MCP‐1 is associated with a faster decline of cognitive function in MCI and dementia due to Alzheimer's disease

Fuh, J., Lee, W., Liao, Y., & Wang, S. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.06.306 · Cited by 2

Peripheral Inflammatory Cytokines as Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment

Guerreiro, R. J., Santana, I. J., Brás, J., Santiago, B., Paiva, A. A., & Oliveira, C. R. (2007) · Neurodegenerative Diseases · doi:10.1159/000107700 · Cited by 150

P2‐009: The chemokines IL8 and MIP‐1b distinguish mild cognitive impairment from early stage Alzheimer's disease

Gonçalves, M., Santana, I. J., Francisco, N., Cunha, C., Batista, S., Kodandaraman, G., & Souto‐Carneiro, M. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.712